Advertisement
Screener

INSMED INC (INSM) Revenues

2.8 / 5 stars · 68/120 Roast Me

INSMED INC Revenues

INSMED INC (INSM) reported Revenues of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-30.

Discontinued › Income Statement

us-gaap:Revenues · last filed 2018-10-30

  • INSMED INC revenues for the quarter ending 2018-09-30 was $0.00.
  • INSMED INC revenues for the quarter ending 2018-06-30 was $0.00.
  • INSMED INC revenues for the quarter ending 2018-03-31 was $0.00.
  • INSMED INC revenues for the quarter ending 2017-12-31 was $0.00.
  • INSMED INC revenues for fiscal 2017 was $0.00.
  • INSMED INC revenues for fiscal 2016 was $0.00.
  • INSMED INC revenues for fiscal 2015 was $0.00.
  • INSMED INC revenues for fiscal 2013 was $11.50M.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2018-09-30$0.00
10-Q · filed 2018-10-30
$0.00
derived: sum of 2 quarters · filed 2018-10-30
$0.00
10-Q · filed 2018-10-30
$0.00
derived: sum of 4 quarters · filed 2018-10-30
2018-06-30$0.00
10-Q · filed 2018-08-02
$0.00
10-Q · filed 2018-08-02
$0.00
derived: sum of 3 quarters · filed 2018-08-02
$0.00
derived: sum of 4 quarters · filed 2018-10-30
2018-03-31$0.00
10-Q · filed 2018-05-02
$0.00
derived: sum of 2 quarters · filed 2018-05-02
$0.00
derived: sum of 3 quarters · filed 2018-10-30
$0.00
derived: sum of 4 quarters · filed 2018-10-30
2017-12-31$0.00
10-K · filed 2018-02-23
$0.00
derived: sum of 2 quarters · filed 2018-10-30
$0.00
derived: sum of 3 quarters · filed 2018-10-30
$0.00
10-K · filed 2018-02-23
2017-09-30$0.00
10-Q · filed 2018-10-30
$0.00
derived: sum of 2 quarters · filed 2018-10-30
$0.00
10-Q · filed 2018-10-30
$0.00
derived: sum of 4 quarters · filed 2018-10-30
2017-06-30$0.00
10-Q · filed 2018-08-02
$0.00
10-Q · filed 2018-08-02
$0.00
derived: sum of 3 quarters · filed 2018-08-02
$0.00
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$0.00
10-Q · filed 2018-05-02
$0.00
derived: sum of 2 quarters · filed 2018-05-02
$0.00
derived: sum of 3 quarters · filed 2018-05-02
$0.00
derived: sum of 4 quarters · filed 2018-05-02
2016-12-31$0.00
10-K · filed 2018-02-23
$0.00
derived: sum of 2 quarters · filed 2018-02-23
$0.00
derived: sum of 3 quarters · filed 2018-02-23
$0.00
10-K · filed 2018-02-23
2016-09-30$0.00
10-K · filed 2018-02-23
$0.00
derived: sum of 2 quarters · filed 2018-02-23
$0.00
10-Q · filed 2017-11-02
2016-06-30$0.00
10-K · filed 2018-02-23
$0.00
derived: sum of 2 quarters · filed 2018-02-23
2016-03-31$0.00
10-K · filed 2018-02-23
2015-12-31$0.00
10-K · filed 2018-02-23
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$0.00
derived: sum of 2 quarters · filed 2016-02-25
$11.50M
derived: sum of 3 quarters · filed 2016-02-25
$11.50M
10-K · filed 2016-02-25
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
$11.50M
derived: sum of 2 quarters · filed 2015-02-27
$11.50M
10-Q · filed 2013-11-05
2013-06-30$11.50M
10-K · filed 2015-02-27
$11.50M
10-Q · filed 2013-08-06
2012-12-31$0.00
10-K · filed 2013-03-18
$0.00
derived: sum of 2 quarters · filed 2013-03-18
$0.00
derived: sum of 3 quarters · filed 2013-03-18
$0.00
10-K · filed 2013-03-18
2012-09-30$0.00
10-K · filed 2013-03-18
$0.00
derived: sum of 2 quarters · filed 2013-03-18
$0.00
10-Q · filed 2012-11-07
$1.40M
derived: sum of 4 quarters · filed 2013-03-18
2012-06-30$0.00
10-K · filed 2013-03-18
$0.00
10-Q · filed 2012-08-07
$1.40M
derived: sum of 3 quarters · filed 2013-03-18
$1.84M
derived: sum of 4 quarters · filed 2013-03-18
2012-03-31$0.00
10-K · filed 2013-03-18
$1.40M
derived: sum of 2 quarters · filed 2013-03-18
$1.84M
derived: sum of 3 quarters · filed 2013-03-18
$2.82M
derived: sum of 4 quarters · filed 2013-03-18
2011-12-31$1.40M
10-K · filed 2013-03-18
$1.84M
derived: sum of 2 quarters · filed 2013-03-18
$2.82M
derived: sum of 3 quarters · filed 2013-03-18
$4.42M
10-K · filed 2014-03-06
2011-09-30$435.00K
10-K · filed 2013-03-18
$1.41M
derived: sum of 2 quarters · filed 2013-03-18
$3.01M
10-Q · filed 2012-11-07
$4.33M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$978.00K
10-K · filed 2013-03-18
$2.58M
10-Q · filed 2012-08-07
$3.90M
derived: sum of 3 quarters · filed 2013-03-18
$5.71M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$1.60M
10-K · filed 2013-03-18
$2.92M
derived: sum of 2 quarters · filed 2013-03-18
$4.73M
derived: sum of 3 quarters · filed 2013-03-18
$6.59M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$3.13M
derived: sum of 2 quarters · filed 2013-03-18
$4.99M
derived: sum of 3 quarters · filed 2013-03-18
$6.92M
10-K · filed 2013-03-18
2010-09-30$1.81M
10-Q · filed 2011-11-09
$3.67M
derived: sum of 2 quarters · filed 2011-11-09
$5.60M
10-Q · filed 2011-11-09
2010-06-30$1.86M
10-Q/A · filed 2011-08-08
$3.79M
10-Q/A · filed 2011-08-08
2009-12-31$10.37M
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10